PATENT CLAIM ANALYSIS

Application Number: 15971250
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["424", "135100"]

Abstract:
The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same.

Claim (Index 45):
The nucleic acid of  claim 44 , which comprises a heavy chain comprising the amino acid sequence of SEQ ID NO: 16 and a light chain comprising the amino acid sequence of SEQ ID NO: 26.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 93.0
- Lexical Diversity: 1.16216
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14307515', '14307519', '15346026', '15390067', '15233026']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7776973926860205
- 35 USC 102 Novelty (BERT): 0.5877240659025789
- Combined Prediction Score: 0.7587000600076763
- Mean Citation Score: 503.60958
- Max Citation Score: 530.95294
- Similarity Product: 406.67392302539713

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test